Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof
dc.contributor.author | Nyce, Jonathan W. | |
dc.date.accessioned | 2016-02-05T17:06:31Z | |
dc.date.available | 2016-02-05T17:06:31Z | |
dc.date.issued | 1996-06-18 | |
dc.description.abstract | A method of combatting cancer in a subject comprising administering to said subject dehydroepiandrosterone (DHEA) or an analog thereof in an amount effective to combat cancer is disclosed in which heart failure induced by the DHEA or analog thereof is combatted by administering to the subject a ubiquinone, in an amount effective to combat heart failure induced by the DHEA or analog thereof. A prefered DHEA analog for carrying out the invention is 16 alpha-fluoroepiandrosterone, and a preferred ubiquinone for carrying out the invention is Coenzyme Q.sub.10. | en_US |
dc.identifier.other | U.S. Patent No. 5,527,789 | |
dc.identifier.uri | http://hdl.handle.net/10342/5176 | |
dc.title | Method of inhibiting carcinogenesis by treatment with dehydroepiandrosterone and analogs thereof | en_US |
dc.type | Patent | en_US |
Files
Original bundle
1 - 1 of 1